BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28099917)

  • 61. Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis.
    Wang Q; Shen B; Chen L; Zheng P; Feng H; Hao Q; Liu X; Liu L; Xu S; Chen J; Teng J
    Oncogene; 2015 Feb; 34(8):1006-18. PubMed ID: 24632605
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Internal modulation of proteolysis in vascular extracellular matrix remodeling: role of ADAM metallopeptidase with thrombospondin type 1 motif 5 in the development of intracranial aneurysm rupture.
    Wang W; Zhang H; Hou C; Liu Q; Yang S; Zhang Z; Yang W; Yang X
    Aging (Albany NY); 2021 May; 13(9):12800-12816. PubMed ID: 33934089
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elevated expression and altered processing of fibulin-1 protein in human breast cancer.
    Greene LM; Twal WO; Duffy MJ; McDermott EW; Hill AD; O'Higgins NJ; McCann AH; Dervan PA; Argraves WS; Gallagher WM
    Br J Cancer; 2003 Mar; 88(6):871-8. PubMed ID: 12644824
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of ADAMTS4 and ADAMTS5 during early orthodontic tooth movement.
    Muraglie S; Musumeci G; Loreto C; Leonardi RM
    J Biol Regul Homeost Agents; 2019 Mar-Apr,; 33(2):649-655. PubMed ID: 30968682
    [No Abstract]   [Full Text] [Related]  

  • 65. Loss of fibulin-2 expression is involved in the inhibition of breast cancer invasion and forms a new barrier in addition to the basement membrane.
    Tan H; Zhang J; Fu D; Zhu Y
    Oncol Lett; 2017 Sep; 14(3):2663-2668. PubMed ID: 28928811
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The extracellular matrix proteins fibulin-1 and fibulin-2 in the early human embryo.
    Miosge N; Götz W; Sasaki T; Chu ML; Timpl R; Herken R
    Histochem J; 1996 Feb; 28(2):109-16. PubMed ID: 8737292
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Host-produced ADAMTS4 Inhibits Early-Stage Tumor Growth.
    Asano K; Edamatsu M; Hatipoglu OF; Inagaki J; Ono M; Ohtsuki T; Oohashi T; Hirohata S
    Acta Med Okayama; 2018 Jun; 72(3):257-266. PubMed ID: 29926003
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ADAMTS Proteins: Concepts, Challenges, and Prospects.
    Apte SS
    Methods Mol Biol; 2020; 2043():1-12. PubMed ID: 31463898
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The quest for substrates and binding partners: A critical barrier for understanding the role of ADAMTS proteases in musculoskeletal development and disease.
    Satz-Jacobowitz B; Hubmacher D
    Dev Dyn; 2021 Jan; 250(1):8-26. PubMed ID: 32875613
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ADAMTS-12: Functions and Challenges for a Complex Metalloprotease.
    Mohamedi Y; Fontanil T; Cal S; Cobo T; Obaya ÁJ
    Front Mol Biosci; 2021; 8():686763. PubMed ID: 33996918
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fibulin-2: A potential regulator of immune dysfunction after bone trauma.
    Li S; Jiang H; Wang S; Li Y; Guo D; Zhan J; Li Q; Meng H; Chen A; Chen L; Dai X; Li X; Xing W; Li L; Fei J
    Immun Inflamm Dis; 2023 May; 11(5):e846. PubMed ID: 37249292
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ADAMTS3 restricts cancer invasion in models of early breast cancer progression through enhanced fibronectin degradation.
    Gibson SV; Madzharova E; Tan AC; Allen MD; Keller UAD; Louise Jones J; Carter EP; Grose RP
    Matrix Biol; 2023 Aug; 121():74-89. PubMed ID: 37336268
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.
    Johnsen M; Lund LR; Rømer J; Almholt K; Danø K
    Curr Opin Cell Biol; 1998 Oct; 10(5):667-71. PubMed ID: 9818179
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fibulins and cancer: friend or foe?
    Gallagher WM; Currid CA; Whelan LC
    Trends Mol Med; 2005 Jul; 11(7):336-40. PubMed ID: 15961345
    [TBL] [Abstract][Full Text] [Related]  

  • 75. EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion.
    Zuo T; Shan J; Liu Y; Xie R; Yu X; Wu C
    Transl Oncol; 2018 Apr; 11(2):346-352. PubMed ID: 29428518
    [TBL] [Abstract][Full Text] [Related]  

  • 76. ADAMTS-12 metalloprotease is necessary for normal inflammatory response.
    Moncada-Pazos A; Obaya AJ; Llamazares M; Heljasvaara R; Suárez MF; Colado E; Noël A; Cal S; López-Otín C
    J Biol Chem; 2018 Jul; 293(29):11648. PubMed ID: 30030383
    [No Abstract]   [Full Text] [Related]  

  • 77. Neurocan is a New Substrate for the ADAMTS12 Metalloprotease: Potential Implications in Neuropathies.
    Fontanil T; Mohamedi Y; Moncada-Pazos A; Cobo T; Vega JA; Cobo JL; García-Suárez O; Cobo J; Obaya ÁJ; Cal S
    Cell Physiol Biochem; 2019; 52(5):1003-1016. PubMed ID: 30977985
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targets in the Tumour Matrisome to Promote Cancer Therapy Response.
    Jalil SMA; Henry JC; Cameron AJM
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791926
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lung Inflammatory Phenotype in Mice Deficient in Fibulin-2 and ADAMTS-12.
    Mohamedi Y; Fontanil T; Vega JA; Cobo T; Cal S; Obaya ÁJ
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396702
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fibulin-2 Facilitates Malignant Progression of Hepatocellular Carcinoma.
    Hu X; Liu T; Li L; Gan H; Wang T; Pang P; Mao J
    Turk J Gastroenterol; 2023 Jun; 34(6):635-644. PubMed ID: 37162505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.